As Bovie Medical (BVX) Market Value Rose, Holder Perkins Capital Management Upped Holding; Vestor Capital Continues to Hold Stake in Facebook Cl A (FB)

Bovie Medical Corporation (NYSEAMERICAN:BVX) Logo

Vestor Capital Llc increased its stake in Facebook Inc Cl A (FB) by 28.35% based on its latest 2018Q3 regulatory filing with the SEC. Vestor Capital Llc bought 5,780 shares as the company’s stock declined 13.60% with the market. The institutional investor held 26,170 shares of the technology company at the end of 2018Q3, valued at $4.30 million, up from 20,390 at the end of the previous reported quarter. Vestor Capital Llc who had been investing in Facebook Inc Cl A for a number of months, seems to be bullish on the $418.20B market cap company. The stock increased 1.20% or $1.72 during the last trading session, reaching $145.52. About 13.55M shares traded. Facebook, Inc. (NASDAQ:FB) has declined 21.26% since January 14, 2018 and is downtrending. It has underperformed by 21.26% the S&P500. Some Historical FB News: 21/03/2018 – Latitude CIO Lait Favors Alphabet Over Facebook (Video); 12/04/2018 – Facebook CEO Tells Congress Regulation Is ‘Inevitable’ (Video); 25/04/2018 – FACEBOOK 1Q EPS $1.69, EST. $1.35; 28/03/2018 – The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Facebook,; 23/03/2018 – U.S. SENATE COMMERCE COMMITTEE LEADERS ASK FACEBOOK CEO ZUCKERBERG TO TESTIFY BEFORE CONGRESS — STATEMENT; 21/03/2018 – African Markets – Factors to watch on March 21; 11/04/2018 – Rep. French Hill on Facebook, Data Collection, Ryan, Syria (Video); 30/05/2018 – Facebook COO @sherylsandberg and CTO Mike Schroepfer closed out the first evening of #CodeCon 2018 last night – watch the full video and read the transcript of their interview with @karaswisher and @pkafka here; 25/04/2018 – Rep. Sarbanes: Top Democrats Press Mark Zuckerberg for More Information about Facebook’s Role in American Democracy; 04/04/2018 – Facebook’s Mark Zuckerberg to Appear at House Committee

Perkins Capital Management Inc increased its stake in Bovie Medical Corp (BVX) by 16.13% based on its latest 2018Q3 regulatory filing with the SEC. Perkins Capital Management Inc bought 64,650 shares as the company’s stock rose 4.93% while stock markets declined. The institutional investor held 465,350 shares of the medical and dental instruments company at the end of 2018Q3, valued at $3.30 million, up from 400,700 at the end of the previous reported quarter. Perkins Capital Management Inc who had been investing in Bovie Medical Corp for a number of months, seems to be bullish on the $215.16 million market cap company. The stock increased 1.09% or $0.07 during the last trading session, reaching $6.48. About 129,549 shares traded. Bovie Medical Corporation (NYSEMKT:BVX) has risen 154.04% since January 14, 2018 and is uptrending. It has outperformed by 154.04% the S&P500. Some Historical BVX News: 31/05/2018 – Bovie Medical Corporation to Participate in the JMP Securities 2018 Life Science Conference; 14/05/2018 – Bovie Medical Corporation Announces Completion of Enrollment in J-Plasma┬«/RenuvionTM Dermal Resurfacing Study; 27/03/2018 – BVX: $BVX FDA approval… no PR yet; 26/03/2018 – bovie medical corp. | freezpoint | K180211 | 03/21/2018 |; 21/03/2018 – FDA: Bovie Medical Corporation- J-Plasma Precise 360(R), Catalog Numbers: BVX-330BR, BVX-330NR, BVX-450BR, BVX-450NR; 12/03/2018 – Bovie Medical 4Q Loss/Shr 3c; 14/05/2018 – BOVIE MEDICAL CORP – REAFFIRMS FISCAL YEAR 2018 FINANCIAL OUTLOOK; 29/03/2018 – Bovie Medical Corporation Announces Launch of Renuvion™: A New Brand Dedicated to the Cosmetic Surgery Market; 04/05/2018 – BOVIE MEDICAL CORP FILES TO OFFER $25M IN MIXED SECURITIES; 21/03/2018 – FDA: Bovie Medical Corporation- J-Plasma Precise(R) FLEX, Catalog Number: BVX-500BF

Vestor Capital Llc, which manages about $525.40 million and $516.10M US Long portfolio, decreased its stake in Abbott Laboratories (NYSE:ABT) by 8,115 shares to 211,244 shares, valued at $15.50 million in 2018Q3, according to the filing. It also reduced its holding in Bank Of America Corp (NYSE:BAC) by 15,836 shares in the quarter, leaving it with 435,012 shares, and cut its stake in Intel Corp (NASDAQ:INTC).

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Nasdaq.com which released: “Nasdaq 100 Movers: FB, INCY – Nasdaq” on December 31, 2018, also Livetradingnews.com with their article: “Facebook, Inc. (NASDAQ:FB) Target $150 – Live Trading News” published on January 10, 2019, Nasdaq.com published: “Noteworthy Tuesday Option Activity: FB, AAPL, DE – Nasdaq” on January 08, 2019. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: Seekingalpha.com and their article: “Facebook’s Zuckerberg paused stock sales in rough fourth quarter – Seeking Alpha” published on January 03, 2019 as well as Seekingalpha.com‘s news article titled: “Crash Protection Kicks In For Facebook – Seeking Alpha” with publication date: December 24, 2018.

Investors sentiment increased to 1.13 in 2018 Q3. Its up 0.04, from 1.09 in 2018Q2. It is positive, as 123 investors sold FB shares while 598 reduced holdings. 154 funds opened positions while 661 raised stakes. 1.61 billion shares or 3.39% less from 1.66 billion shares in 2018Q2 were reported. Chevy Chase Trust Hldgs owns 1.99 million shares. Dimensional Fund Advisors Lp holds 0.33% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 5.23M shares. Jacobs & Company Ca has 1.99% invested in Facebook, Inc. (NASDAQ:FB) for 71,565 shares. Evermay Wealth Mngmt Lc reported 0.54% stake. Webster Natl Bank N A stated it has 0.64% of its portfolio in Facebook, Inc. (NASDAQ:FB). Kornitzer Cap Management Ks stated it has 76,077 shares or 0.2% of all its holdings. Corda Invest Lc accumulated 7,469 shares or 0.15% of the stock. Tokio Marine Asset Limited holds 92,586 shares. Kwmg Ltd Liability Corp invested in 590 shares or 0.02% of the stock. Moreover, Hartford Fincl Management has 0.12% invested in Facebook, Inc. (NASDAQ:FB). Riggs Asset Managment Communication Inc reported 1.05% in Facebook, Inc. (NASDAQ:FB). Kamunting Street Mgmt Limited Partnership owns 15.93% invested in Facebook, Inc. (NASDAQ:FB) for 106,034 shares. Wall Street Access Asset Ltd reported 7,444 shares. 25,460 are held by Mirador Cap Partners L P. Moreover, Toth Financial Advisory Corp has 0.03% invested in Facebook, Inc. (NASDAQ:FB) for 790 shares.

Since July 16, 2018, it had 0 insider purchases, and 61 insider sales for $985.98 million activity. Sandberg Sheryl also sold $7.79 million worth of Facebook, Inc. (NASDAQ:FB) shares. 272,128 shares were sold by Zuckerberg Mark, worth $46.51 million. FISCHER DAVID B. sold $392,937 worth of stock. Cox Christopher K sold 10,600 shares worth $1.92M. $6.33M worth of stock was sold by Schroepfer Michael Todd on Tuesday, September 11. Wehner David M. sold $1.72M worth of stock or 9,522 shares.

Among 57 analysts covering Facebook (NASDAQ:FB), 48 have Buy rating, 2 Sell and 7 Hold. Therefore 84% are positive. Facebook had 310 analyst reports since July 21, 2015 according to SRatingsIntel. BTIG Research downgraded the stock to “Neutral” rating in Friday, July 22 report. The firm has “Buy” rating by BTIG Research given on Tuesday, March 21. As per Thursday, April 28, the company rating was maintained by Nomura. The firm has “Buy” rating given on Thursday, November 5 by Rosenblatt. The firm earned “Buy” rating on Monday, October 9 by Canaccord Genuity. FBR Capital maintained it with “Outperform” rating and $118 target in Thursday, July 30 report. On Thursday, November 5 the stock rating was maintained by Pivotal Research with “Buy”. The rating was maintained by RBC Capital Markets with “Buy” on Friday, January 12. The company was maintained on Wednesday, September 27 by Wells Fargo. KeyBanc Capital Markets maintained the stock with “Buy” rating in Monday, April 9 report.

Bovie Medical Corporation (NYSEAMERICAN:BVX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.